Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 31 March 2020 394,834,698
Employee options over ordinary shares at 31 March 2020

19,330,750

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd on 31 March 2020 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 107,538 27%
2. Arix Bioscience Holdings Limited 43,693 11%
3. National Nominees Limited 25,982 7%
4. HSBC Custody Nominees (Australia) Limited  25,523 6%
5. JP Morgan Nominees Australia Limited 13,301 3%
6. Moggs Creek Pty Ltd (Moggs Creek Super A/C) 7,098 2%
7.  Dr Toby David Cohen 3,316 1%
8. BNP Paribas Nominees Pty Ltd (BNPP NYB Clearing Acc DRP)  2,658 1%
9.  Mr Yingkali Li 2,400 1%
10. Healthcare Management Consulting (Australia) Pty Ltd 2,220 1%
 11. Ms Beu Xu + Mr Dongning Wu 2,123 1% 
12. Pakasoluto Pty Limited (Barkl Family Super Fund) 2,036 1%
13. Joseph Wallace Carson 2,000 1%
14. George Engineering Pty Ltd (PG Super Fund) 1,750 0%
14. Simgon Pty Ltd (RK Super A/C) 1,750 0%
16. Mr Marco Andrea Negro 1,400 0%
17. DR Newnham Super Pty Ltd 1,527 0%
18. Blair House Pty Ltd (Robert Stork SF A/C) 1,500 0%
18. Jarhamche Pty Ltd 1,500 0%
20. Mr Warren Patrick Hackett (Warren Hackett S/F A/C) 1,455 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 

Name Percent Date 
BVF Partners LP 21% 30 May 2019
Arix Bioscience Holdings Limited 11% 25 September 2018
Australian Ethical Australian Share Fund 8% 25 September 2018
D&A Income Limited 7% 28 February 2019

Directors' Interests

Current director's interest notices can be found here: